• Nitches pivoted to a supplements and lifestyle-enhancement strategy built around a manufacturing platform for outside founders.
• Planned offering targets concept-to-distribution execution, aiming to cut regulatory, financial, operational risk before capital is committed.
• Operations will run through an FDA-compliant manufacturing partner, with each product routed through internal R&D and a product-integrity qualification gate.
• Management plans to open a portfolio of more than 200 pre-approved nutraceutical and OTC formulations to qualified white-label clients under licensing.
• In coming weeks, it expects to launch an intelligence platform that scans formulations against enforcement data, scores claims, builds auditable compliance records in under 30 seconds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nitches Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606040830ACCESSWRNAPR_____1173041) on June 04, 2026, and is solely responsible for the information contained therein.